Although exercise adherence showed a favorable trend (OR = 1.49), the difference did not reach statistical significance, likely due to limited sample size and relatively short intervention duration.
← all phrases
“a favorable trend”
Sighted at
p=0.09
In the literature
For functional mobility, although there was a favorable trend in improvement, such improvement did not reach statistical significance.
Although maternal adverse outcomes did not differ significantly between groups (13/30, 43% vs 11/30, 37%), a favorable trend was observed.
The median OS was similar, but the HR showed a favorable trend, indicating that this combination strategy could be a potential first-line treatment for non-squamous NSCLC.
Nevertheless, the proportion of men in our study (women/ men = 1.87) showed a slight increase when compared to the ratio found in a previous study (2.15) from a similar population followed in the CVHP [ 10 ], possibly reflecting a favorable trend in the recruitment of men to the program (please see Table 4 ).
Our study also found a favorable trend but no significant difference of IV t‐PA on functional outcome in the restricted sample of sEICAS ≥ 50%, partly because of the limited sample size ( n = 124).
Nevertheless, the CPET parameters began to show a favorable trend even at low doses [ 25 ].
For patients with diabetes mellitus, our analysis suggests a favorable trend concerning the effect of 25(OH)D on eGFR and UACR without significant differences.
Although regional data point towards a favorable trend in prevention, important challenges remain, including the cost of vaccination programs, coverage of 2 vaccine doses, and the need to vaccinate susceptible populations like those living with HIV and other individuals with immunodeficiency.
concluded that InO had superior efficacy in terms of rates of remission and hematopoietic stem cell transplantation (HSCT) and a favorable trend on event-free survival (EFS) compared to blinatumomab.
When combined aerobic and resistance training was compared with controls, previous studies have shown a significant reduction in HbA1c and a favorable trend for glycemia [71] , [72] .
The shortnose sturgeon plan [5] names 19 distinct populations and specifies three recovery criteria: adequate size with a favorable trend in abundance; habitat sufficient to support a recovered population; and potential causes of mortality insufficient to reduce the population.
Although the difference in OS (63.2 versus 51.1 months) did not reach statistical significance ( p = 0.156), a favorable trend was observed.
By contrast, oncogenic driver identity provided outcome-relevant biological stratification independent of age: RET fusions, NTRK1/3 fusions, and BRAF V600E were associated with significantly higher odds of a non-excellent response after adjustment, whereas RAS-mutant tumors showed a favorable trend and DICER1-mutant cases achieved excellent outcomes in the modeled cohort.
They identified a favorable trend in fosinopril despite no statistical significance and suggested that the statistical significance might have occurred when the sample size exceeded 476 patients for each group.
Although improvements in usual activities and anxiety/depression were not statistically significant, a favorable trend was evident.
While other domains of satisfaction showed a favorable trend toward the gunsight technique, the differences did not reach statistical significance—likely because of the limited sample size.
Lipid Metabolism In the pilot study of patients with MetS, TRE led to significant reduction of atherogenic lipids such as total cholesterol (~7%), low-density lipoprotein cholesterol (LDL-C) (~11%) and non-high-density lipoprotein cholesterol levels (~9%), and a favorable trend towards reduction was found for TG and LDL-C particle number [ 16 ].
Because this meta-analysis revealed an I 2 value of 0%, indicating low statistical heterogeneity among the included studies, the pooled results suggested a favorable trend toward a reduced risk of OM in patients receiving chemotherapy.
Interim analysis revealed a significant improvement in radiographic progression-free survival and a favorable trend in overall survival.
As a result, the OS benefit showed a favorable trend for the afatinib group compared with the osimertinib group, as shown in Figure 3 , and Supplementary Figure S4 , available at https://doi.org/10.1016/j.esmoop.2021.100115 .
(6) Among the tested mixtures, appropriate ceramsite replacement showed a favorable trend in permeability grade and residual strength.
Updated data from this trial demonstrated a favorable trend in overall survival and response even within the pMMR subgroup, although statistical significance was not reached [ 14 ].
The group that received this treatment showed a favorable trend in median survival (16.6 vs. 10.9 months); however, it was not statistically significant ( P = 0.755).
As a result, while our evidence map visually suggests a favorable trend toward TCM efficacy in PHD, the underlying uncertainty must not be overlooked.